vs
Side-by-side financial comparison of PATRIOT NATIONAL BANCORP INC (PNBK) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $9.5M, roughly 1.4× PATRIOT NATIONAL BANCORP INC). On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 44.3%). TriSalus Life Sciences, Inc. produced more free cash flow last quarter ($-2.5M vs $-14.3M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 11.5%).
Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
PNBK vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.5M | $13.2M |
| Net Profit | — | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | -36.3% | -24.8% |
| Net Margin | — | -73.9% |
| Revenue YoY | 44.3% | 59.8% |
| Net Profit YoY | — | 3.5% |
| EPS (diluted) | $0.13 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.5M | $13.2M | ||
| Q3 25 | $7.2M | $11.6M | ||
| Q2 25 | $6.2M | $11.2M | ||
| Q1 25 | $6.7M | $9.2M | ||
| Q4 24 | $6.6M | $8.3M | ||
| Q3 24 | $7.1M | $7.3M | ||
| Q2 24 | $7.1M | $7.4M | ||
| Q1 24 | $7.7M | $6.5M |
| Q4 25 | — | $-9.8M | ||
| Q3 25 | $-2.7M | $-10.8M | ||
| Q2 25 | $-5.0M | $-8.3M | ||
| Q1 25 | $-2.8M | $-10.4M | ||
| Q4 24 | — | $-10.1M | ||
| Q3 24 | $-27.0M | $-2.4M | ||
| Q2 24 | $-3.1M | $-4.3M | ||
| Q1 24 | $-299.0K | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | -36.3% | -24.8% | ||
| Q3 25 | -36.9% | -77.9% | ||
| Q2 25 | -81.2% | -65.4% | ||
| Q1 25 | -41.5% | -79.9% | ||
| Q4 24 | -205.4% | -91.8% | ||
| Q3 24 | -32.4% | -118.9% | ||
| Q2 24 | -56.5% | -111.0% | ||
| Q1 24 | -3.0% | -180.8% |
| Q4 25 | — | -73.9% | ||
| Q3 25 | -36.8% | -93.5% | ||
| Q2 25 | -80.4% | -73.9% | ||
| Q1 25 | -41.6% | -113.2% | ||
| Q4 24 | — | -122.4% | ||
| Q3 24 | -378.9% | -32.6% | ||
| Q2 24 | -43.5% | -58.8% | ||
| Q1 24 | -3.9% | -204.5% |
| Q4 25 | $0.13 | $-0.22 | ||
| Q3 25 | $-0.03 | $-0.96 | ||
| Q2 25 | $-0.06 | $-0.27 | ||
| Q1 25 | $-0.21 | $-0.39 | ||
| Q4 24 | $-2.40 | $-0.38 | ||
| Q3 24 | $-6.78 | $-0.12 | ||
| Q2 24 | $-0.77 | $-0.21 | ||
| Q1 24 | $-0.08 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $20.4M |
| Total DebtLower is stronger | $16.4M | — |
| Stockholders' EquityBook value | $94.7M | $-33.9M |
| Total Assets | $1.1B | $35.3M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $22.7M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $16.5M | ||
| Q1 24 | — | $4.0M |
| Q4 25 | $16.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $33.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $94.7M | $-33.9M | ||
| Q3 25 | $95.0M | $-26.7M | ||
| Q2 25 | $66.2M | $-19.4M | ||
| Q1 25 | $57.1M | $-34.4M | ||
| Q4 24 | $4.3M | $-25.9M | ||
| Q3 24 | $16.4M | $-20.4M | ||
| Q2 24 | $40.5M | $-25.3M | ||
| Q1 24 | $43.6M | $-36.0M |
| Q4 25 | $1.1B | $35.3M | ||
| Q3 25 | $950.8M | $36.5M | ||
| Q2 25 | $930.0M | $41.3M | ||
| Q1 25 | $956.6M | $28.6M | ||
| Q4 24 | $1.0B | $24.0M | ||
| Q3 24 | $974.1M | $27.5M | ||
| Q2 24 | $1.0B | $32.4M | ||
| Q1 24 | $1.1B | $17.9M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.76× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.2M | $-2.5M |
| Free Cash FlowOCF − Capex | $-14.3M | $-2.5M |
| FCF MarginFCF / Revenue | -150.8% | -19.1% |
| Capex IntensityCapex / Revenue | 1.8% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-24.6M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-14.2M | $-2.5M | ||
| Q3 25 | $-5.2M | $-3.7M | ||
| Q2 25 | $921.0K | $-7.3M | ||
| Q1 25 | $-5.8M | $-4.5M | ||
| Q4 24 | $2.7M | $-5.7M | ||
| Q3 24 | $-2.6M | $-10.8M | ||
| Q2 24 | $6.0M | $-13.4M | ||
| Q1 24 | $1.8M | $-10.9M |
| Q4 25 | $-14.3M | $-2.5M | ||
| Q3 25 | $-5.3M | $-3.9M | ||
| Q2 25 | $918.0K | $-7.4M | ||
| Q1 25 | $-5.9M | $-5.3M | ||
| Q4 24 | $2.6M | $-5.8M | ||
| Q3 24 | $-2.7M | $-11.0M | ||
| Q2 24 | $6.0M | $-13.5M | ||
| Q1 24 | $1.8M | $-10.9M |
| Q4 25 | -150.8% | -19.1% | ||
| Q3 25 | -72.8% | -33.9% | ||
| Q2 25 | 14.8% | -66.1% | ||
| Q1 25 | -88.0% | -57.3% | ||
| Q4 24 | 39.9% | -69.7% | ||
| Q3 24 | -37.3% | -149.9% | ||
| Q2 24 | 84.6% | -183.1% | ||
| Q1 24 | 23.0% | -169.3% |
| Q4 25 | 1.8% | 0.3% | ||
| Q3 25 | 0.3% | 1.9% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 1.0% | 8.2% | ||
| Q4 24 | 0.8% | 0.6% | ||
| Q3 24 | 0.9% | 2.3% | ||
| Q2 24 | 0.7% | 0.8% | ||
| Q1 24 | 0.5% | 1.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
